Ipilimumab has efficacy in metastatic Merkel cell carcinoma: a case series of five patients

J Eur Acad Dermatol Venereol. 2017 Sep;31(9):e389-e391. doi: 10.1111/jdv.14193. Epub 2017 Mar 22.

Authors

J K Winkler¹, A Dimitrakopoulou-Strauss², C Sachpekidis², A Enk¹, J C Hassel¹

Affiliations

¹ Department of Dermatology and National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.
² Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany.

PMID: 28256019
DOI: 10.1111/jdv.14193

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Aged, 80 and over
Antineoplastic Agents, Immunological / therapeutic use*
Carcinoma, Merkel Cell / drug therapy*
Carcinoma, Merkel Cell / secondary*
Female
Humans
Ipilimumab / therapeutic use*
Male
Middle Aged
Retrospective Studies
Skin Neoplasms / drug therapy*
Skin Neoplasms / pathology*
Treatment Outcome

Substances

Antineoplastic Agents, Immunological
Ipilimumab